Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Watch the full video on Radcliffe Cardiology here:

In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral regurgitation.

Discussion points:
- The reason for the Intrepid TMVR study
- Study design and patient population
- Key Findings
- Further research

Recorded Remotely from Portland, 2021.
Interviewer: Jordan Rance

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.

Чтобы скачать видео "TCT 2021: Intrepid TMVR: Results Show Improved NYHA Class at 30 Days | Dr Firas Zahr" передвинте ползунок вправо